Statistics for A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer
Total visits
| views | |
|---|---|
| A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer | 247 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Heinemann_2016_A-study.pdf | 262 |
Top country views
| views | |
|---|---|
| United States | 150 |
| Germany | 17 |
| Ukraine | 9 |
| China | 8 |
| Japan | 5 |
| Russia | 4 |
| Sweden | 4 |
| Australia | 3 |
| Canada | 3 |
| United Kingdom | 2 |
| Italy | 2 |
| Spain | 1 |
| Greece | 1 |
| Ireland | 1 |
| Israel | 1 |
| Malaysia | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 47 |
| Fairfield | 17 |
| Kiez | 13 |
| Ann Arbor | 11 |
| Kiev | 9 |
| Cambridge | 8 |
| Houston | 8 |
| Jacksonville | 7 |
| Beijing | 3 |
| Chicago | 3 |
| Rockville | 3 |
| Saint Petersburg | 3 |
| Stockholm | 3 |
| Tokyo | 3 |
| Washington | 3 |
| Duncan | 2 |
| Grùmolo | 2 |
| Guangzhou | 2 |
| Lake Mary | 2 |
| San Francisco | 2 |
| Toronto | 2 |
| White Plains | 2 |
| Abingdon | 1 |
| Borås | 1 |
| Brooklyn | 1 |
| Canberra | 1 |
| Chongqing | 1 |
| Clayton | 1 |
| Dublin | 1 |
| Gunzenhausen | 1 |
| Hamilton | 1 |
| Irvine | 1 |
| Kaohsiung | 1 |
| Kwinana | 1 |
| Leipzig | 1 |
| Moscow | 1 |
| Mountain View | 1 |
| Norwalk | 1 |
| Philadelphia | 1 |
| Piraeus | 1 |
| San Sebastian | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Setagaya | 1 |
| Shenzhen | 1 |
| Tel Aviv | 1 |
| Ube | 1 |
| Wuppertal | 1 |